|
|
||||||||
Genes1



*
Division of Immune Regulation, La Jolla Institute for Allergy and Immunology, San Diego, CA 92121,
Anergen, Redwood City, CA 94063; and
Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA 90095
The 524543 region of glutamic acid decarboxylase (GAD65),
GAD65(524543), is one of the first fragments of this islet Ag to
induce proliferative T cell responses in the nonobese diabetic (NOD)
mouse model of spontaneous autoimmune diabetes. Furthermore, NOD mice
given tolerogenic doses of GAD65(524543) are protected from
spontaneous and cyclophosphamide-induced diabetes. In this study, we
report that there are at least two I-Ag7-restricted
determinants present in the GAD65(524543) sequence, each capable of
recruiting unique T cell repertoires characterized by distinct TCR
V
gene use. CD4+ T cells arise
spontaneously in young NOD mice to an apparently dominant determinant
found within the GAD65 peptide 530543 (p530); however, T cells to the
overlapping determinant 524538 (p524) dominate the response only
after immunization with GAD65(524543). All p530-responsive T cells
used the V
4 gene, whereas the
V
12 gene is preferentially used to
encode the TCR of p524-responsive T cell populations. T cell clones and
hybridomas from both of these T cell groups were responsive to APC
pulsed with GAD65(524543) or whole rGAD65. p524-reactive cells
appeared to be regulatory upon adoptive transfer into young NOD mice
and could inhibit insulin-dependent diabetes mellitus development,
although they were unable to produce IL-4, IL-10, or TGF
upon
antigenic challenge. Furthermore, we found that i.p. injection with
p524/IFA was very effective in providing protection from
cyclophosphamide-induced insulin-dependent diabetes mellitus. These
data demonstrate that the regulatory T cells elicited by immunizing
with GAD65(524543) are unique and distinct from those that arise from
spontaneous endogenous priming, and that T cells to this limited region
of GAD65 may be either regulatory or pathogenic.
This article has been cited by other articles:
![]() |
F. Fallarino, G. Luca, M. Calvitti, F. Mancuso, C. Nastruzzi, M. C. Fioretti, U. Grohmann, E. Becchetti, A. Burgevin, R. Kratzer, et al. Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone J. Exp. Med., October 26, 2009; 206(11): 2511 - 2526. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Burton, E. Vincent, P. Y. Arnold, G. P. Lennon, M. Smeltzer, C.-S. Li, K. Haskins, J. Hutton, R. M. Tisch, E. E. Sercarz, et al. On the Pathogenicity of Autoantigen-Specific T-Cell Receptors Diabetes, May 1, 2008; 57(5): 1321 - 1330. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Martinic, A. E. Juedes, D. Bresson, D. Homann, K. Skak, C. Huber, E. Ling, M. Ejrnaes, T. Wolfe, L. Togher, et al. Minimal Impact of a De Novo-Expressed {beta}-Cell Autoantigen on Spontaneous Diabetes Development in NOD Mice Diabetes, April 1, 2007; 56(4): 1059 - 1068. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Quinn, M. McInerney, D. Huffman, B. McInerney, S. Mayo, K. Haskins, and E. Sercarz T cells to a dominant epitope of GAD65 express a public CDR3 motif Int. Immunol., June 1, 2006; 18(6): 967 - 979. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Fallarino, U. Grohmann, S. You, B. C. McGrath, D. R. Cavener, C. Vacca, C. Orabona, R. Bianchi, M. L. Belladonna, C. Volpi, et al. The Combined Effects of Tryptophan Starvation and Tryptophan Catabolites Down-Regulate T Cell Receptor {zeta}-Chain and Induce a Regulatory Phenotype in Naive T Cells. J. Immunol., June 1, 2006; 176(11): 6752 - 6761. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. D. Dai, K. P. Jensen, A. Lehuen, E. L. Masteller, J. A. Bluestone, D. B. Wilson, and E. E. Sercarz A Peptide of Glutamic Acid Decarboxylase 65 Can Recruit and Expand a Diabetogenic T Cell Clone, BDC2.5, in the Pancreas J. Immunol., September 15, 2005; 175(6): 3621 - 3627. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Olcott, J. Tian, V. Walker, H. Dang, B. Middleton, L. Adorini, L. Washburn, and D. L. Kaufman Antigen-Based Therapies Using Ignored Determinants of {beta} Cell Antigens Can More Effectively Inhibit Late-Stage Autoimmune Disease in Diabetes-Prone Mice J. Immunol., August 1, 2005; 175(3): 1991 - 1999. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Han, Y. Li, J. Wang, R. Wang, G. Chen, L. Song, R. Xu, M. Yu, X. Wu, J. Qian, et al. Active Tolerance Induction and Prevention of Autoimmune Diabetes by Immunogene Therapy Using Recombinant Adenoassociated Virus Expressing Glutamic Acid Decarboxylase 65 Peptide GAD500-585 J. Immunol., April 15, 2005; 174(8): 4516 - 4524. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Gregg, R. Jain, S. J. Schoenleber, R. Divekar, J. J. Bell, H.-H. Lee, P. Yu, and H. Zaghouani A Sudden Decline in Active Membrane-Bound TGF-{beta} Impairs Both T Regulatory Cell Function and Protection against Autoimmune Diabetes J. Immunol., December 15, 2004; 173(12): 7308 - 7316. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Y. Arnold, A. R. Burton, and D. A. A. Vignali Diabetes Incidence Is Unaltered in Glutamate Decarboxylase 65-Specific TCR Retrogenic Nonobese Diabetic Mice: Generation by Retroviral-Mediated Stem Cell Gene Transfer J. Immunol., September 1, 2004; 173(5): 3103 - 3111. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Durai, H. R. Kim, and K. D. Moudgil The Regulatory C-Terminal Determinants within Mycobacterial Heat Shock Protein 65 Are Cryptic and Cross-Reactive with the Dominant Self Homologs: Implications for the Pathogenesis of Autoimmune Arthritis J. Immunol., July 1, 2004; 173(1): 181 - 188. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Herman, G. J. Freeman, D. Mathis, and C. Benoist CD4+CD25+ T Regulatory Cells Dependent on ICOS Promote Regulation of Effector Cells in the Prediabetic Lesion J. Exp. Med., June 7, 2004; 199(11): 1479 - 1489. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Quintana, P. Carmi, F. Mor, and I. R. Cohen DNA Fragments of the Human 60-kDa Heat Shock Protein (HSP60) Vaccinate Against Adjuvant Arthritis: Identification of a Regulatory HSP60 Peptide J. Immunol., October 1, 2003; 171(7): 3533 - 3541. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chen, W.-H. Lee, P. Yun, P. Snow, and C.-P. Liu Induction of Autoantigen-Specific Th2 and Tr1 Regulatory T Cells and Modulation of Autoimmune Diabetes J. Immunol., July 15, 2003; 171(2): 733 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Hall, F. J. Ward, M. A. Vickers, L.-M. Stott, S. J. Urbaniak, and R. N. Barker Interleukin-10-mediated regulatory T-cell responses to epitopes on a human red blood cell autoantigen Blood, December 15, 2002; 100(13): 4529 - 4536. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yoshida, T. Martin, K. Yamamoto, C. Dobbs, C. Munz, N. Kamikawaji, N. Nakano, H.-G. Rammensee, T. Sasazuki, K. Haskins, et al. Evidence for shared recognition of a peptide ligand by a diverse panel of non-obese diabetic mice-derived, islet-specific, diabetogenic T cell clones Int. Immunol., December 1, 2002; 14(12): 1439 - 1447. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tian, A. P. Olcott, and D. L. Kaufman Antigen-Based Immunotherapy Drives the Precocious Development of Autoimmunity J. Immunol., December 1, 2002; 169(11): 6564 - 6569. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Quintana, P. Carmi, and I. R. Cohen DNA Vaccination with Heat Shock Protein 60 Inhibits Cyclophosphamide-Accelerated Diabetes J. Immunol., November 15, 2002; 169(10): 6030 - 6035. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Baker, M. Lee, Y.-h. Chien, and M. M. Davis Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice PNAS, July 9, 2002; 99(14): 9374 - 9379. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. L. Chiu, A. M. Jevnikar, and J. S. Danska Genetic Control of T and B Lymphocyte Activation in Nonobese Diabetic Mice J. Immunol., December 15, 2001; 167(12): 7169 - 7179. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tian, S. Gregori, L. Adorini, and D. L. Kaufman The Frequency of High Avidity T Cells Determines the Hierarchy of Determinant Spreading J. Immunol., June 15, 2001; 166(12): 7144 - 7150. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Paas-Rozner, M. Sela, and E. Mozes The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes PNAS, October 23, 2001; 98(22): 12642 - 12647. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |